03 November 1997
Coronary stent implantation results in patients treated with ticlopidine and aspirin
Maciej KośmiderMed Sci Monit 1997; 3(6): CR821-825 :: ID: 501788
Abstract
Antiplatelet drugs gradually replace anticoagulants in patients subjected to coronary artery stenting. The purpose of this paper is to present our own experiences associated with combined treatment with ticlopidine and aspirin. From June 1995 until December 1996 118 patients were subjected to placement of 127 coronary stents in our laboratory (including 58 PS, 52 GR II, 11 Wiktor and 6 NIR stents). The procedure was performed in planned course in 101 patients, while in 17 patients - in situation threatening of sudden occlusion of coronary artery (bail-out) or in its factual occurrence. All patients were treated with 10 000 IU of heparin IV, Aspirin 250 mg/day PO and Ticlopidine 2i250 mg. If the stent implantation was a planned course procedure, ticlopidine had been started three days before. If the decision was made during the angioplasty, the patient was treated with 500 mg during the procedure of stent placement. The drug was administered for 30 days unless side effects occurred. PS 153 and NIR stents were distended under high pressure of 16-18 Atm, Wiktor and GR II of 8-13 atm. No systematic ICUS control was conducted. None of the patients who had successful stent implantation had haemorrhagic complications or thrombosis symptoms. During 8-month follow-up period clinical symptoms of restenosis occurred in 10 cases, out of which 7 in the stent and 3 before or after it, as diagnosed on a control coronarography. Conclusion: Ticlopidine and Aspirin combined treatment provides good immediate and long term effect in coronary stent implantation, irrespective of the course of the procedure.
Keywords: Angioplasty, coronary stent implantation, antiplatelet treatment
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
15 Mar 2024 : Clinical Research
Impact of One-Lung Ventilation on Oxygenation and Ventilation Time in Thoracoscopic Heart Surgery: A Compar...Med Sci Monit In Press; DOI: 10.12659/MSM.943089
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952